Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc
Bullboard Posts
User Avatar Image
(36)
•••
Comment by TankRebel2012on Aug 20, 2018 1:35pm
89 Views
Post# 28487557

RE:Time to sell WCoyote

RE:Time to sell WCoyoteOh look... copy paste with no real results once again....Morris is talk talk talk with out of this world number's.  Fire him.    


Big Clive guy i truly believe now he using #SQD as his tax write offs each year now with no profit returns for years. People that make alot of money needs lost's too for tax reasons.  

he funding with write off a canadian tech, in the end does hefeel he'll lose out ...? nope because he a biggest insider holder which when they scrap this company he'll make sure he get's his rewards like the rest of the insiders holding.  

Public holders will have veryVery little say on the deal and likely get pushed out.

SQI has mislead investors for YEARS!!!  investors guildine the company made up hasn't EVEN reach 90% results in income and contracts it's be just purly WORDS OF LIES they was suppose to be profitable end of 2017.....now middle of 2018.....WAIT!!!! now 2019...??? haha company revune under 1m now for a year market cap 20m current share price means it's only worth the stock price 2-4 cent's......

BIG CLIFF is coming!!   BANG entering the nickle world.

BUYER BEWARE   SQI HAS BEEN MISLEADING INVESTORS FOR YEARS
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities